hexoprenaline has been researched along with Hemangioma in 1 studies
Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.
Hemangioma: A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayer, M | 1 |
| Minichmayr, A | 1 |
| Klement, F | 1 |
| Hroncek, K | 1 |
| Wertaschnigg, D | 1 |
| Arzt, W | 1 |
| Wiesinger-Eidenberger, G | 1 |
| Lechner, E | 1 |
1 other study available for hexoprenaline and Hemangioma
| Article | Year |
|---|---|
Tocolysis with the β-2-sympathomimetic hexoprenaline increases occurrence of infantile haemangioma in preterm infants.
Topics: Adrenergic beta-2 Receptor Agonists; Female; Glucocorticoids; Hemangioma; Hexoprenaline; Humans; Inf | 2013 |